Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 06-2021 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -248 | N/A | N/A | N/A |
| Other Working Capital | -67 | -3 | N/A | N/A |
| Other Operating Activity | -2 | 0 | 0 | 0 |
| Operating Cash Flow | $-316 | $-3 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Purchase Of Investment | -45,186 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -3,190 | 0 | 0 |
| Investing Cash Flow | $-45,186 | $-3,190 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 300 | N/A | N/A | N/A |
| Common Stock Issued | 47,472 | N/A | N/A | N/A |
| Common Stock Repurchased | -25 | N/A | N/A | N/A |
| Other Financing Activity | -1,766 | 205 | 0 | 0 |
| Financing Cash Flow | $45,981 | $205 | $N/A | $N/A |
| End Cash Position | 479 | N/A | N/A | N/A |
| Net Cash Flow | $479 | $-2,988 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -316 | -3 | N/A | N/A |
| Free Cash Flow | -316 | -3 | 0 | 0 |